iJak-381 | m-entrepreneurship.com

Product Name :
iJak-381

Search keywords :
iJak-381

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK1

Target Vo Short Name :
JAK1

Moa_Name:
Tyrosine-protein kinase JAK1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genentech Inc

Active Company_Name :
Genentech Inc

Active Indication_Name:
Asthma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ifinatamab Cancer
Magrolimab Description
STAT1 Antibody (YA667): STAT1 Antibody (YA667) is a non-conjugated and Mouse origined monoclonal antibody about 87kDa, targeting to STAT1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts